Hartman-Houstman, H.; Swenson, S.; Minea, R.O.; Sinha, U.K.; Chiang, M.-F.; Chen, T.C.; Schönthal, A.H.
Activation of Epstein–Barr Virus’ Lytic Cycle in Nasopharyngeal Carcinoma Cells by NEO212, a Conjugate of Perillyl Alcohol and Temozolomide. Cancers 2024, 16, 936.
https://doi.org/10.3390/cancers16050936
AMA Style
Hartman-Houstman H, Swenson S, Minea RO, Sinha UK, Chiang M-F, Chen TC, Schönthal AH.
Activation of Epstein–Barr Virus’ Lytic Cycle in Nasopharyngeal Carcinoma Cells by NEO212, a Conjugate of Perillyl Alcohol and Temozolomide. Cancers. 2024; 16(5):936.
https://doi.org/10.3390/cancers16050936
Chicago/Turabian Style
Hartman-Houstman, Hannah, Steve Swenson, Radu O. Minea, Uttam K. Sinha, Ming-Fu Chiang, Thomas C. Chen, and Axel H. Schönthal.
2024. "Activation of Epstein–Barr Virus’ Lytic Cycle in Nasopharyngeal Carcinoma Cells by NEO212, a Conjugate of Perillyl Alcohol and Temozolomide" Cancers 16, no. 5: 936.
https://doi.org/10.3390/cancers16050936
APA Style
Hartman-Houstman, H., Swenson, S., Minea, R. O., Sinha, U. K., Chiang, M. -F., Chen, T. C., & Schönthal, A. H.
(2024). Activation of Epstein–Barr Virus’ Lytic Cycle in Nasopharyngeal Carcinoma Cells by NEO212, a Conjugate of Perillyl Alcohol and Temozolomide. Cancers, 16(5), 936.
https://doi.org/10.3390/cancers16050936